Patrick Soon Shiong Bio | Wiki
Patrick Soon Shiong is a Chinese-South African billionaire businessman, transplant surgeon, bioscientist, and media proprietor. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.
Patrick is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups. Moreover, he serves as an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles.
Patrick has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.
Patrick Soon Shiong Age
Patrick was born on July 29, 1952, in Gqeberha, South Africa. He is 70 years old.
Patrick Soon Shiong Height
He is a man of average stature and stands at a height of 5 ft 7 in (Approx. 1.70 m).
Patrick Soon Shiong Family
He was born and raised in Port Elizabeth, the Republic of South Africa. Patrick’s parents were Chinese immigrants who fled from China during the Japanese occupation in World War II. They were Hakka originally from Meixian District in Guangdong province. Patrick’s ancestral surname is Huang. He has a brother named Terrence.
Patrick Soon Shiong Wife
Patrick is married to his beautiful wife Michele B. Chan. She is a philanthropist and former actress. Together, the couple shares two children and live in Los Angeles, California.
Patrick Soon Shiong Education
He graduated 4th out of his class of 189 from the University of Witwatersrand, receiving a bachelor’s degree in medicine (MBBCh) at age 23. Patrick completed his medical internship at Johannesburg’s General Hospital. He then studied at the University of British Columbia, where he earned a master’s degree in 1979.
He received research awards from the American College of Surgeons, the Royal College of Physicians and Surgeons of Canada, and the American Association of Academic Surgery. Patrick moved to the United States and began surgical training at the University of California, Los Angeles (UCLA), and became a board-certified surgeon in 1984.
Patrick Soon Shiong Lakers | La Times
He has been a minority owner of the Los Angeles Lakers since 2010. Since June 2018, Patrick has been the owner and executive chairman of the Los Angeles Times and The San Diego Union-Tribune.
Patrick Soon Shiong Vaccine | Clinical Trials
In early 2021, Patrick merged a publicly traded company NantKwest (NASDAQ: NK) with a privately held entity ImmunityBio. The new public entity after the merger is known as ImmunityBio, Inc. trading in NASDAQ under the ticker symbol: IBRX.
By summer 2021, ImmunityBio had developed a T cell-inducing universal COVID-19 vaccine booster shot that had reached Phase III trials in his native South Africa.
It had a stated goal of completely blocking transmission and stemming an endemic tide of COVID-19 variants. In December 2021, Patrick shared pre-clinical results of giving two different vaccine platforms (heterologous) and showed beneficial T cell levels using an adenovirus and mRNA technology. In Feb 2022, he announced results from ImmunityBio regarding a clinical trial in Non-Muscle Invasive Bladder Cancer (NMIBC) with a 24.1 median duration and 71% complete remission.
Patrick Soon Shiong Forbes
As of April 2021, Patrick is estimated by Forbes to have a net worth of US$11.5 billion. He has committed to the Giving Pledge and has pledged to give away at least half of his wealth to philanthropy.
Patrick Soon Shiong South Africa
In September 2021, Patrick and President Cyril Ramaphosa of South Africa announced via a virtual press conference a new venture called NantSA with NantWorks to expand the capability of vaccine development for Africa.
NantWorks has signed a collaboration agreement with the South African government’s Council for Scientific and Industrial Research, the South African Medical Research Council (SAMRC), and the Centre for Epidemic Response and Innovation.
In January 2022, Patrick opened a new manufacturing facility and campus in Cape Town, South Africa with President Ramaphosa. He and his entities are reported to be investing over 4 billion RAND (~$250 million dollars) into the continent.
Patrick Soon Shiong Net Worth
He earns his wealth from his career, therefore, he has amassed a fortune over the years. Patrick’s estimated net worth is $6.7 billion.
Who Is Patrick Soon Shiong
Patrick is a Chinese-South African billionaire businessman, transplant surgeon, bioscientist, and media proprietor. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.